[1]董 谦,陈 康,王伟佳.多重指标在急性冠脉综合症中的应用价值[J].医学信息,2021,34(05):172-175.[doi:10.3969/j.issn.1006-1959.2021.05.050]
　DONG Qian,CHEN Kang,WANG Wei-jia.The Application Value of Multiple Indexes in Acute Coronary Syndrome[J].Medical Information,2021,34(05):172-175.[doi:10.3969/j.issn.1006-1959.2021.05.050]
点击复制

多重指标在急性冠脉综合症中的应用价值()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年05期
页码:
172-175
栏目:
诊疗技术
出版日期:
2021-03-01

文章信息/Info

Title:
The Application Value of Multiple Indexes in Acute Coronary Syndrome
文章编号:
1006-1959（2021）05-0172-04
作者:
董 谦; 陈 康; 王伟佳
（中山大学附属中山医院检验医学中心，广东 中山 528403）
Author(s):
DONG Qian; CHEN Kang; WANG Wei-jia
(Laboratory Medicine Center,Zhongshan Hospital,Sun Yat-sen University,Zhongshan 528403,Guangdong,China)
关键词:
急性冠脉综合征; 高敏C反应蛋白; N末端B型利钠肽前体
Keywords:
Acute coronary syndrome; High sensitivity C-reactive protein; N-terminal B-type natriuretic peptide precursor
分类号:
R543.3
DOI:
10.3969/j.issn.1006-1959.2021.05.050
文献标志码:
A
摘要:
目的 探讨心肌同工酶MB（CK-MB）、N末端B型利钠肽前体（NT-proBNP）、高敏C反应蛋白（hs-CRP）、甘油三酯（TG）、高密度脂蛋白（HDL-C）、低密度脂蛋白（LDL-C）、脂蛋白（a）[Lp（a）]在急性冠脉综合症（ACS）患者中的临床价值。方法 收集2017年10月~2018年2月中山市人民医院诊断为ACS患者85例作为ACS组，其中AMI56例、UA29例；KillipⅠ级25例、KillipⅡ级23例、Killip（Ⅲ~Ⅳ）级8例；单支血管病变25例、双支血管病变31例、三支血管病变29例，另选取85例健康体检者作为对照组，比较ACS组、对照组及ACS组中不同疾病类型、Killip心功能分级、冠脉造影结果间实验室指标[NT-proBNP、CK-MB、hs-CRP、HDL、TG、LDL、Lp（a）]差异。结果 ACS组CK-MB、NT-proBNP、hs-CRP、TG、HDL均高于对照组，LDL低于对照组，差异有统计学意义（P＜0.05）；两组Lp（a）比较，差异无统计学意义（P＞0.05）。AMI患者CK-MB、NT-proBNP、hs-CRP、HDL均高于UA患者，LDL低于UA患者，差异有统计学意义（P＜0.05）；两者TG和LP（a)比较，差异无统计学意义（P＞0.05）。Killip（Ⅲ~Ⅳ）患者NT-proBNP、CK-MB、hs-CRP均高于KillipⅡ患者和KillipⅠ患者，且KillipⅡ患者高于KillipⅠ患者，差异有统计学意义（P＜0.05）；三者TG、LDL、HDL、LP（a）比较，差异无统计学意义（P＞0.05）。单支血管病变患者NT-proBNP、CK-MB、hs-CRP均低于双支血管病变患者和三支血管病变患者，差异有统计学意义（P＜0.05）；三支血管病变患者NT-proBNP、hs-CRP均高于双支血管病变患者，差异有统计学意义（P＜0.05）；三者TG、LDL、HDL、LP（a）比较，差异无统计学意义（P＞0.05）。结论 血清CK-MB、NT-proBNP和hs-CRP与心功能分级和血管病变程度密切相关，且对ACS的诊断和病情的评估有一定应用价值。
Abstract:
Objective To explore myocardial isoenzyme MB (CK-MB), N-terminal B-type natriuretic peptide precursor (NT-proBNP), high-sensitivity C-reactive protein (hs-CRP), triglyceride (TG), high-density lipoprotein (HDL -C), low-density lipoprotein (LDL-C), lipoprotein (a) [Lp (a)] clinical value in patients with acute coronary syndrome (ACS).Methods A total of 85 patients diagnosed with ACS from Zhongshan People’s Hospital from October 2017 to February 2018 were collected as the ACS group, of which 56 were AMI and 29 were UA;25 cases of Killip Ⅰ, 23 Killip Ⅱ, 8 Killip (Ⅲ~Ⅳ); 25 cases of single vessel disease, 31 cases of double vessel disease, 29 cases of three vessel disease.In addition, 85 healthy subjects were selected as the control group to compare the ACS group with the control group and the ACS group in different disease types, Killip cardiac function classification, coronary angiography results and laboratory indicators [NT-proBNP, CK-MB, hs- CRP, HDL, TG, LDL, Lp(a)] difference.Results CK-MB, NT-proBNP, hs-CRP, TG, HDL in the ACS group were higher than those in the control group.LDL was lower than the control group, the difference was statistically significant (P＜0.05);There was no significant difference in Lp(a) between the two groups (P>0.05).The CK-MB, NT-proBNP, hs-CRP, and HDL of AMI were higher than those of UA, and the LDL was lower than UA, the difference was statistically significant (P<0.05);There was no statistically significant difference between TG and LP(a) between the two (P>0.05).NT-proBNP, CK-MB and hs-CRP in Killip (Ⅲ~Ⅳ) were higher than KillipⅡ and KillipⅠ, and KillipⅡ was higher than KillipⅠ, the difference was statistically significant (P<0.05);Comparison of TG, LDL, HDL, LP(a) among the three, the difference was not statistically significant (P>0.05).NT-proBNP, CK-MB, and hs-CRP in patients with single-vessel disease were lower than those with double-vessel disease and three-vessel disease, the difference was statistically significant (P<0.05);NT-proBNP and hs-CRP in three-vessel patients were higher than those with double-vessel disease,the difference was statistically significant (P<0.05);Comparison of TG, LDL, HDL, LP(a) among the three, the difference was not statistically significant (P>0.05).Conclusion Serum CK-MB, NT-proBNP and hs-CRP are closely related to the classification of heart function and the degree of vascular disease, and have certain application value in the diagnosis and evaluation of ACS.

参考文献/References:

[1]Li J,Li X,Wang Q,et al.ST-segment elevation myocardial infarction in China from 2001 to 2011(the China PEACE-Retrospective Acute Myocardial Infarction Study):A retrospective analysis of hospital data[J].Lancet,2015(385):441-451. [2]Ma Q,Wang J,Jin J,et al.Clinical characteristics and prognosis of acute coronary syndrome in young women and men:A systematic review and meta-analysis of prospective studies[J].Int J Cardiol,2017(228):837-843. [3]Dallmeier D,Pencina MJ,Rajman I,et al.Serial measurements of N-Terminal Pro-Brain natriuretic peptide in patients with coronary heart disease[J].PLoS One,2015,10(1):e0117143. [4]Castro AR,Silva SO,Soares SC.The use of high sensitivity c-reactive protein in cardiovascular disease detection[J].J Pharm Pharm Sci,2018,21(1):496-503. [5]Penalva RA,Huoya Mde O,Correia LC,et al.Lipid profile and intensity of atherosclerosis disease in acute coronary syndrome[J]. Arq Bras Cardiol,2008,90(1):24-30. [6]Sanchis-Gomar F,Perez-Quilis C,Leischik R,et al.Epidemiology of coronary heart disease and acute coronary syndrome[J].Ann Transl Med,2016,4(13):256. [7]Abdelghany M,Subedi R,Shah S,et al.Kounis syndrome:A review article on epidemiology,diagnostic findings,management and complications of allergic acute coronary syndrome[J].Int J Cardiol,2017(232):1-4. [8]Grabowski M,Filipiak KJ,Malek LA,et al.Admission B-type natriuretic peptide assessment improves early risk stratification by Killip classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated with primary angioplasty[J].Int J Cardiol,2007,115(3):386-390. [9]Alpert JS,Antman E,Apple F,et al.Myocardial infarction redefined-A consensus document of the Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction[J].Eur Heart,2000,36(3):959-969. [10]Biasucci LM.C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women[J].N Engl J Med,2000,342(12):836-843. [11]Zhang H,Dong P,Yang X,et al.Prognostic indicators of new onset atrial fibrillation in patients with acute coronary syndrome[J].Clin Cardiol,2020,43(6):647-651. [12]Yilmaz S,Adali MK,Kilic O,et al.Predictors of in-hospital mortality in very eldery patients presenting with acute coronary syndrome:A single-center study[J].Turk Kardiyol Dern Ars,2019,47(1):38-44. [13]Zhang Y,Zhu CG,Guo YL,et al.Fibrinogen and the Severity of Coronary Atherosclerosis among Adults with and without Statin Treatment:Lipid as a mediator[J].Hear Lung Circ,2016,25(6):558-567. [14]Nakagawa K,Nakashima Y.Pathologic intimal thickening in human atherosclerosis is formed by extracellular accumulation of plasma-derived lipids and dispersion of intimal smooth muscle cells[J].Atherosclerosis,2018(274):235-242.

相似文献/References:

[1]赵殿儒,祁景蕊.不同剂量瑞舒伐他汀对急性冠脉综合征患者心功能和炎症因子的影响[J].医学信息,2019,32(01):148.[doi:10.3969/j.issn.1006-1959.2019.01.046]
　ZHAO Dian-ru,YAN Jing-rui.Effects of Different Doses of Rosuvastatin on Cardiac Function and Inflammatory Factors in Patients with Acute Coronary Syndrome[J].Medical Information,2019,32(05):148.[doi:10.3969/j.issn.1006-1959.2019.01.046]
[2]镡子鸣,叶怀阔,任长杰.超敏C反应蛋白及妊娠相关血浆蛋白A预测再发急性冠脉综合征的临床价值[J].医学信息,2019,32(08):173.[doi:10.3969/j.issn.1006-1959.2019.08.055]
　TAN Zi-ming,YE Huai-kuo,et al.Clinical Value of High-sensitivity C-reactive Protein and Pregnancy-associated Plasma Protein A in Predicting Recurrent Acute Coronary Syndrome[J].Medical Information,2019,32(05):173.[doi:10.3969/j.issn.1006-1959.2019.08.055]
[3]梁道博,姚卜飞,夏双燕.氯吡格雷联合阿司匹林治疗急性冠脉综合征疗效与 安全性的Meta分析[J].医学信息,2019,32(11):76.[doi:10.3969/j.issn.1006-1959.2019.11.021]
　LIANG Dao-bo,YAO Bu-fei,XIA Shuang-yan.Meta-analysis of the Efficacy and Safety of Clopidogrel Combined with Aspirin in the Treatment of Acute Coronary Syndrome[J].Medical Information,2019,32(05):76.[doi:10.3969/j.issn.1006-1959.2019.11.021]
[4]张牧秋,古俊楠,刘 瑜,等.NOACS治疗房颤合并急性冠脉综合征的研究[J].医学信息,2019,32(13):28.[doi:10.3969/j.issn.1006-1959.2019.13.010]
　ZHANG Mu-qiu,GU Jun-nan,LIU Yu,et al.Study of NOACS in the Treatment of Atrial Fibrillation Complicated with Acute Coronary Syndrome[J].Medical Information,2019,32(05):28.[doi:10.3969/j.issn.1006-1959.2019.13.010]
[5]王建强,刘 瑜,张牧秋,等.房颤伴ACS患者经皮冠状动脉介入术后抗栓研究[J].医学信息,2019,32(14):35.[doi:10.3969/j.issn.1006-1959.2019.14.013]
　WANG Jian-qiang,LIU Yu,ZHANG Mu-qiu,et al.Study on Antithrombotic after Percutaneous Coronary Intervention in Patients with Atrial Fibrillation and ACS[J].Medical Information,2019,32(05):35.[doi:10.3969/j.issn.1006-1959.2019.14.013]
[6]孙 洋,高 山,宋 京,等.血尿酸、同型半胱氨酸、脑钠肽、肌钙蛋白Ⅰ与急性冠脉综合征病变程度的相关性[J].医学信息,2020,33(02):105.[doi:10.3969/j.issn.1006-1959.2020.02.028]
　SUN Yang,GAO Shan,SONG Jing,et al.Correlation Between Serum Uric Acid,Homocysteine,Brain Natriuretic Peptide,TroponinⅠ and the Severity of Acute Coronary Syndrome[J].Medical Information,2020,33(05):105.[doi:10.3969/j.issn.1006-1959.2020.02.028]
[7]史作霞,张文彦,李 馨,等.改良桡动脉止血器在老年ACS患者动脉穿刺后压迫止血中的效果[J].医学信息,2020,33(02):184.[doi:10.3969/j.issn.1006-1959.2020.02.060]
　SHI Zuo-xia,ZHANG Wen-yan,LI Xin,et al.Evaluation of Improved Radial Arterial Hemostatic Device in Compression Hemostasis After Arterial Puncture in Elderly Patients with ACS[J].Medical Information,2020,33(05):184.[doi:10.3969/j.issn.1006-1959.2020.02.060]
[8]葛 敏,屈晓冰.NLR及hs-CRP水平与高血压病患者动态血压负荷的相关性分析[J].医学信息,2020,33(21):79.[doi:10.3969/j.issn.1006-1959.2020.21.023]
　GE Min,QU Xiao-bing.Correlation Analysis Between NLR and hs-CRP Levels and Ambulatory Blood Pressure Load in Patients with Hypertension[J].Medical Information,2020,33(05):79.[doi:10.3969/j.issn.1006-1959.2020.21.023]
[9]夏 雪,顾 明.急性冠脉综合征患者血清Gal-3浓度与病变程度及肌钙蛋白的相关性[J].医学信息,2021,34(01):116.[doi:10.3969/j.issn.1006-1959.2021.01.030]
　XIA Xue,GU Ming.Correlation of Serum Gal-3 Concentration with Disease Degree and Troponin in Patients with Acute Coronary Syndrome[J].Medical Information,2021,34(05):116.[doi:10.3969/j.issn.1006-1959.2021.01.030]
[10]王 楠.血栓通注射液对急性冠脉综合征介入治疗后血脂、炎症因子及内皮功能的影响[J].医学信息,2021,34(09):122.[doi:10.3969/j.issn.1006-1959.2021.09.032]
　WANG Nan.Effect of Xueshuantong Injection on Blood Lipid,Inflammatory Factors and Endothelial Function After Interventional Therapy for Acute Coronary Syndrome[J].Medical Information,2021,34(05):122.[doi:10.3969/j.issn.1006-1959.2021.09.032]

更新日期/Last Update: 1900-01-01